Literature DB >> 31237533

Molecular characterization of group A rotavirus among children aged under 5 years in Tunisia, 2015-2017.

Haifa Bennour1,2, Imene Fodha1,2, Asma Bouazizi1,2, Meriam Ben Hamida-Rebaï1,2, Amira Jerbi1,2, Mouna Ben Hadj Fredj1,3, Samia Lakhal1,2, Ameni Dhiflaoui1,2, Shada Abdelberi1,2, Fairouz Abbassi1,2, Noureddine Boujaafar4, Akila Fathallah5,6, Saoussen Abroug7, Monia Khlifa8, Abdelhalim Trabelsi1,2.   

Abstract

The aim of the present study was to report the molecular characterization of human group A rotaviruses (RVAs) circulating in Tunisia. Stool specimens were collected from children under 5 years of age who had been hospitalized or were consulting for gastroenteritis in Tunisian hospitals between 2015 and 2017. All samples were screened by reverse-transcription polymerase chain reaction (RT-PCR) for the detection of the VP6 gene specific for RVA. RVA-positive samples were further analysed for G/P genotyping by semi-nested multiplex RT-PCR. Among 454 tested samples, 72 (15.8 %) were positive for RVA. G1P[8] was the most prevalent detected strain (41.7%), followed by G9P[8] (32.8%), G2P[4] (7.5%), G12P[8] (7.5%), G1P[6] (3.0%), G2P[8] (1.5%) and G3P[8] (1.5%), with mixed infections in 4.5 % of cases. In the absence of a national anti-rotavirus vaccination strategy, RVAs remain the primary aetiological agent for gastroenteritis in Tunisian children.

Entities:  

Keywords:  Tunisia; VP4 genotype; VP7 genotype; children; gastroenteritis; group A rotavirus

Mesh:

Substances:

Year:  2019        PMID: 31237533     DOI: 10.1099/jmm.0.001031

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  1 in total

1.  Prevalence and genotypes distribution of group A rotavirus among outpatient children under 5 years with acute diarrhea in Shanghai, China, 2012-2018.

Authors:  Lijuan Lu; Huaqing Zhong; Ran Jia; Liyun Su; Menghua Xu; Lingfeng Cao; Pengcheng Liu; Yuanyun Ao; Niuniu Dong; Jin Xu
Journal:  BMC Gastroenterol       Date:  2022-05-03       Impact factor: 2.847

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.